Treatments

The Relationship Between OSA and Mood Disorders, Cognitive Impairment

By

Tori Rodriquez, MA, LPC, AHC

Publish Date November 27, 2019

Common comorbidities in OSA such as cardiovascular disease and metabolic abnormalities, may confer a higher risk for the development of mental and cognitive impairment in patients with OSA compared with the general population.

The Genetic Link Between Asthma and Mental Health

By

Nicola Davies, PhD

Publish Date November 20, 2019

Investigators suggest that any identified links between asthma and mental health have primarily been unidirectional, with asthma leading to mental illness.

Vaping Injuries Raise New Concerns About Medical Marijuana

By

Bryant Furlow

Publish Date November 19, 2019

Many recent vaping injuries have been linked to e-cigarette use of THC oils or other cannabis oil products, raising new concerns about patients with cancer who use the devices for medical marijuana.

Cannabidiol Gets Orphan Drug Status for Preventing Ischemia-Reperfusion Injury

By

Steve Duffy

The designation was granted to Revive Therapeutics, a company that specializes in cannabis-based pharmaceuticals.

Chest Tube Placement vs Needle Aspiration for Spontaneous Pneumothorax

By

Bryant Moeller

Both chest tube placement and needle aspiration were considered acceptable treatments for primary spontaneous pneumothorax.

NDA for Novel Amikacin Inhalation Submitted for Rare Lung Infection

By

Steve Duffy

ALIS has previously been designated orphan drug status, breakthrough therapy status and a Qualified Infectious Disease Product.

No Benefit From Prophylactic Antimicrobials in Aspiration Pneumonitis

By

Bradley van Paridon

Use of prophylactic antimicrobial therapy was not associated with a reduction in mortality or transfer to critical care compared with patients managed with supportive care only.

Drainage Duration, Length of Hospital Stay With Different Pneumothorax Treatments

By

Anna Kitabjian

Treatment with a small pigtail catheter may shorten the drainage duration and length of hospital stay in patients with spontaneous pneumothorax.

FDA Approves New CFTR Modulator Therapy for Cystic Fibrosis

By

Britt Gambino

A new cystic fibrosis transmembrane conductance regulator modulator treatment has been approved by the FDA for use in patients aged 12 years and older.

Enteral vs Parenteral Nutrition in Critical Care Requiring Mechanical Ventilation

By

Laurel Ranger

Enteral nutritional support was not clinically superior to parenteral nutritional support in critically ill patients receiving mechanical ventilation.

Examining Compression-to-Ventilation Ratios for Optimal Neurologic, Survival Outcomes

By

Anna Kitabjian

Adults with cardiac arrest have better outcomes with continuous compressions with asynchronous ventilations or compression-to-ventilation ratios of 30:2.